Advanced glycation end products as biomarkers for cardiovascular disease: browning clarifying atherogenesis

被引：7
|
作者：
Pinto, R. S. [1 ,2 ]
Machado, U. F. [3 ]
Passarelli, M. [1 ,4 ]
机构：
[1] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP, Lab Lipides LIM 10, Sao Paulo, Brazil
[2] Ctr Univ CESMAC, Maceio, Alagoas, Brazil
[3] Univ Sao Paulo, Inst Ciencias Biomed, Dept Fisiol & Biofis, Sao Paulo, Brazil
[4] Univ Nove Julho UNINOVE, Programa Posgrad Med, Sao Paulo, Brazil
来源：
BIOMARKERS IN MEDICINE | 2020年 / 14卷 / 08期
基金：
巴西圣保罗研究基金会;
关键词：
advanced glycation end products; cardiovascular disease; diabetes mellitus; Maillard reaction; DIABETES-MELLITUS; ALBUMIN; STRESS; MACROPHAGES; PATHWAYS;
D O I：
10.2217/bmm-2020-0060
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：611 / 614
页数：4
相关论文
共 50 条
  • [31] Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular Disease
    Hirai, Tomoya
    Fujiyoshi, Kazuhiro
    Yamada, Satoru
    Matsumoto, Takuya
    Kikuchi, Junko
    Ishida, Kohki
    Ishida, Miwa
    Yamaoka-Tojo, Minako
    Inomata, Takayuki
    Shigeta, Kyo
    Tojo, Taiki
    NUTRIENTS, 2022, 14 (15)
  • [32] Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
    Takanobu Takata
    Akiko Sakasai-Sakai
    Tadashi Ueda
    Masayoshi Takeuchi
    Scientific Reports, 9
  • [33] Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study
    Chen, Jinluan
    Arshi, Banafsheh
    Waqas, Komal
    Lu, Tianqi
    Bos, Daniel
    Ikram, M. Arfan
    Uitterlinden, Andre G.
    Kavousi, Maryam
    Zillikens, M. Carola
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [34] Intracellular toxic advanced glycation end-products in cardiomyocytes may cause cardiovascular disease
    Takata, Takanobu
    Sakasai-Sakai, Akiko
    Ueda, Tadashi
    Takeuchi, Masayoshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
    Tomoya Hirai
    Kazuhiro Fujiyoshi
    Satoru Yamada
    Takuya Matsumoto
    Junko Kikuchi
    Kohki Ishida
    Miwa Ishida
    Kyo Shigeta
    Taiki Tojo
    Cardiovascular Diabetology, 22
  • [36] Association between fingertip-measured advanced glycation end products and cardiovascular events in outpatients with cardiovascular disease
    Hirai, Tomoya
    Fujiyoshi, Kazuhiro
    Yamada, Satoru
    Matsumoto, Takuya
    Kikuchi, Junko
    Ishida, Kohki
    Ishida, Miwa
    Shigeta, Kyo
    Tojo, Taiki
    CARDIOVASCULAR DIABETOLOGY, 2023, 22 (01)
  • [37] Cardiovascular risk in patients with end-stage renal disease: A potential role for advanced glycation end products
    Wang, YJ
    Marshall, SM
    Thompson, MG
    Hoenich, NA
    CARDIOVASCULAR DISORDERS IN HEMODIALYSIS, 2005, 149 : 168 - 174
  • [38] Advanced glycation end products are associated with cardiovascular risk in the Mexican population
    Robles-Rivera, Karina
    Rivera-Paredez, Berenice
    Quezada-Sanchez, Amado D.
    Velazquez-Cruz, Rafael
    Salmeron, Jorge
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2023, 33 (04) : 826 - 834
  • [39] Are advanced glycation end products cardiovascular risk factors in patients with CRF?
    Stein, G
    Busch, M
    Müller, A
    Wendt, T
    Franke, C
    Niwa, T
    Franke, S
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) : S52 - S56
  • [40] Receptor for Advanced Glycation End Products and Soluble Receptor for Advanced Glycation End Products: A Balancing Act in Chronic Obstructive Pulmonary Disease?
    Sukkar, Maria B.
    Postma, Dirkje S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 188 (08) : 893 - 894
12345